Chris Gibson, Co-Founder; Chairman (as of Jan 2026; previously CEO Nov 2013–Jan 2026)[4][5][13][23][24][25][26][27]

Blake Borgeson, Co-Founder; Board Member (previously CTO Nov 2013–Jul 2018)[4][5][13][23][24][25][26][27]

CHRISTOPHER CORY GIBSON, Co-Founder & Chair, Recursion (NASDAQ:RXRX) | Co-Founder & CEO, BOXBOX | Co-Founder, Project Gamma | Boards: Cellino, Salt Lake Tribune, BioHive | Advisor: A-Alpha Bio | Angel & friend to the best deep-tech companies[4][5][13][23][24][25][26][27]

Ben Taylor, Chief Financial Officer and President of Recursion UK[14][15][16][17][18][19][20][21][22]

Najat Khan, CEO and President[14][15][16][17][18][19][20][21][22]

Insilico Medicine · insilico.com · Same buyer and workflow: integrated TechBio model using AI for end-to-end drug discovery with an internal pipeline, listed as a direct competitor to Recursion Pharmaceuticals on CBInsights and StartupHub alternatives pages.[35][37]

Schrödinger · schrodinger.com · Overlapping pharma R&D buyer and computational drug discovery workflow; listed among Recursion's top alternatives on CBInsights and ZoomInfo competitor pages; competes for the same pharma partnership budget on the platform-licensing side of Recursion's...[35][36]

Relay Therapeutics · relaytx.com · Same integrated TechBio model—proprietary computational platform feeding an internal clinical pipeline in oncology—listed as a comparable on CBInsights and StartupHub alternatives pages for Recursion.[35][37]

Exscientia · exscientia.ai · Direct merger target: Exscientia's chemistry and ClinTech capabilities were absorbed into Recursion OS 2.0; named explicitly in Recursion's own leadership LinkedIn as the 2024 combination deal, making it the closest structural comparable on the AI-native drug...[6]

The customer proof is company-sourced only. No independent source in this ledger confirms it.[1]

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Filled in the side panel for invited readers. This card carries sourced facts only.